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Abstract: The efficacy of blood and buffy coat smear examination, commercially available dot-enzyme-linked immunosorbent assay
(ELISA) kit, and nested polymerase chain reaction (PCR) was evaluated in the diagnosis of canine ehrlichiosis in 40 dogs exhibiting
symptoms suggestive of the disease. The intracytoplasmic rickettsial organisms were seen in the smears of only 1 dog (2.5%) with an
extremely low level of parasitemia. Nested PCR with 16S rRNA revealed characteristic 378 bp bands indicating positive reaction in 8
(20.0%) dogs and sera samples of 21 (52.5%) dogs revealed anti-Ehrlichia antibodies. The dog that revealed organisms in the blood also
showed positive results with the other 2 methods. Similarly all the sera samples of dogs with nPCR positive results were also positive
for anti-Ehrlichia antibodies. The 8 dogs that exhibited positive results by nPCR and dot-ELISA were studied for clinical, hematological,
and biochemical characterization of the disease. Fever, depression, anorexia, anemia, splenomegaly, and bleeding tendency were the
common symptoms associated with the disease. Thrombocytopenia was the most consistent hematological finding, followed by anemia.
Biochemical analysis revealed hyperglobulinemia with a reverse albumin:globulin ratio in 3 cases.
Key words: Dog, Ehrlichia canis, blood smear, hematology, biochemical analysis, clinical signs, ELISA, PCR

1. Introduction
Ehrlichia canis, an etiological agent of canine monocytic
ehrlichiosis or canine hemorrhagic fever, is a small
gram-negative coccoid bacterium that resides and
replicates in the cytoplasm of circulating monocytes and
macrophages. E. canis infection in dogs and other canine
hosts is transmitted biologically by a common dog tick,
Rhipicephalus sanguineus, in which only transstadial
transmission is reported (1). Although the disease has a
global distribution, it is widely prevalent in tropical and
subtropical countries, including India. Among the 4
species of Ehrlichia parasitizing dogs, E. canis has been
reported frequently, while thrombocytic E. platys (2) and
granulocytic Anaplasma phagocytophilum (3) have been
reported sporadically from different parts of India.
The incubation period of canine ehrlichiosis ranges
from 8 to 20 days, after which the clinical entity reveals
3 phases: acute, subclinical, and chronic (4). The
commonly encountered signs such as fever, splenomegaly,
lymphadenopathy, anemia, hemorrhages on mucus
membranes, and conjunctiva and bleeding through natural
orifices in the form of epistaxis, hematemesis, hematuria,
and melena vary considerably in severity and frequency of
occurrence in the initial and terminal phases of infection,
which are well separated by a prolonged subclinical phase.
* Correspondence: riddhi.pednekar@gmail.com
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Since the prognosis of the last 2 phases is invariably
guarded to grave, early confirmative diagnosis of the
disease is urgently required to prevent life threatening or
fatal outcome (5).
Currently diagnosis of canine ehrlichiosis is based
on anamnesis, clinical presentation, and confirmatory
laboratory investigations, which include 2 conventional,
(demonstration of organisms in blood smears and in vitro
cultures), immunological (demonstration of circulating
antibodies), and molecular (demonstration of genus
and species specific DNA by polymerase chain reaction)
approaches. Microscopic demonstration of intracytoplasmic
organisms in monocytes is diagnostic for the disease, but
very few blood samples reveal the organisms owing to low
levels of parasitemia. The cell culture reisolation method
is reported to be very sensitive and definitive, but is not a
convenient method as it requires 14–34 days to give results
and thus defeats the whole purpose of early diagnosis
(6). Serological methods including indirect fluorescent
antibody test (IFAT), enzyme-linked immunosorbent
assay (ELISA), and western blot (WB) assay, are effective
for detection of antibodies to E. canis, but failure of the
techniques to differentiate current and past infections
and early infections (1–3 weeks postinfection), limit
their reliability as a confirmative indicator of the disease.
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Polymerase chain reaction (PCR) based detection of E.
canis though gaining acceptability within the scientific
community to overcome the problems listed above requires
sophisticated laboratory and accurate standardization.
Owing to this, the results are subjectively interpreted as
there may be inter- and intralaboratory variations that, at
present, limit the applicability of the tool in the diagnosis
of the disease. Nevertheless, the molecular approach has
shown encouraging promise not only in the diagnosis
but also in epidemiological studies and analysis of antiEhrlichial chemotherapy (7). Thus diagnosis of the disease
particularly in the subclinical phase poses a serious
challenge for practicing veterinarians. The present work
was therefore undertaken to evaluate laboratory procedures
available for diagnosis of canine ehrlichiosis. Since
immunological and molecular methods are not available
uniformly throughout the country, efforts were also made
to find out hematological and biochemical alterations that
help in the clinical assessment of canine ehrlichiosis.
2. Materials and methods
The dogs presented to pet practitioners in and around
Mumbai and Bai Sakarbai Dinshaw Petit Hospital,
Mumbai, showing at least 2 characteristic clinical
signs of canine ehrlichiosis, which include high fever,
splenomegaly, bleeding from natural orifices, hemorrhages
on mucus membranes, and presence of ticks on the body,
were included in the study. The description of animals and
the clinical history of these dogs were noted. Blood/sera
samples of suspected dogs were subjected to parasitological
(01/40), immunological (21/40), molecular (08/21),
hematological (08/08), and biochemical investigations
(08/08).
2.1. Blood/buffy coat smear examination
Peripheral blood smears and buffy coat smears were
stained with Field stain and Giemsa stain as per the
technique described by Rathore and Sengar (8) for the
demonstration of intracytoplasmic rickettsiae.
2.2. Immunological analysis
For analysis 10 µL of blood or 5-µL sera samples from
suspected dogs were subjected to dot-ELISA using a
commercially available kit (ImmunoComb, Biogal, Galed
Laboratories, Israel) and following the manufacturer’s
protocol.
2.3. Molecular diagnosis of E. canis
In order to improve the efficacy of the test and prevent
interference of hemoglobin in PCR (9), 200 µL of buffy
coat of each sample was used for extraction of 16S rDNA.
For obtaining this 200 µL of buffy coat, 2 mL of blood was
centrifuged. The DNA was extracted by using a Genei pure
blood genomic DNA purification kit (Bangalore Genei,
India), according to the manufacturer’s protocol, but the
sample was incubated overnight in lysis buffer I.

2.3.1. Standard polymerase chain reaction
The PCR protocol as described by Lakshmanan (10)
was followed with a few modifications. A 477 base pair
fragment of 16S rRNA gene was amplified using previously
published genus specific FECC: 5´ AGA AGG AAC GCT
GGC GGC AAG C 3´ and RECB: 5´ CGT ATT ACC
GCG GCT GCT GGC A 3´, primers (8). Amplification
of genus specific reaction was carried out in a 25-μL PCR
tube containing 11.0 μL of dH2O, 2.5 μL of 10X buffer
without MgCl2, 1.2 μL of MgCl2 (mM), primers (30 pmol)
1.0 μL each, 3.0 μL of dNTPs (2.5 mM), and 0.3 μL of
Taq polymerase. Then 5 μL of DNA template was added
to the master mix. Initial denaturation was done at 94 °C
for 4 min followed by annealing at 62 °C for 1 min and
extension at 72 °C for 2 min. After that, 35 cycles at 94 °C
for 1 min, 62 °C for 45 s and 72 °C for 1 min were done. A
final extension at 72 °C for 10 min was done.
2.3.2. Single tube nested polymerase chain reaction
The primers used for species specific nested PCR were
FP: 5´-GTG GCA GAC GGG TGA GTA ATG C 3´ and
RP: 5´-CAG AGT TTG CCG GGA CTT CTT C 3´. The
amplification reaction was carried out in a 25-µL PCR
tube with the following protocol: 15.0 μL of dH2O, 2.5 μL
of 10X buffer without MgCl2, 1.2 μL of MgCl2 (mM), 1.0
μL of species specific primers (30 pmol each), 3.0 μL of
dNTPs (2.5 mM), and 0.3 μL of Taq polymerase to which
1 μL of amplicons of genus specific reaction was added.
The cycling conditions followed were the same as for the
genus specific reaction. Species specific PCR amplicons
obtained at 378 bp were cut from agarose gels and
purified using GeneiPureTM Quick PCR Purification Kit
(Bangalore Genei, India) according to the manufacturer’s
recommendations. DNA sequencing was performed
in both directions by Bangalore Genei. Sequence
chromatograms were read and analyzed.
2.4. Hematology and biochemical analysis of blood and
sera samples
Whole blood samples of confirmed cases were subjected to
blood urea nitrogen (BUN) estimation as per the method
described by Benjamin (11). Sera samples of confirmed
Ehrlichia cases were subjected to a liver function test
(Alanine aminotransferase, aspartate aminotransferase,
and serum bilirubin) and kidney function test (blood
urea nitrogen and serum creatinine) as per the method
described by Benjamin (11).
2.5. Clinical characterization of canine ehrlichiosis
The dogs that tested positive for canine ehrlichiosis either
by blood smear/buffy coat smear examination or by
commercially available ELISA kit and PCR technique were
monitored closely. The dogs were subjected to thorough
physical examination and case history and clinical signs
exhibited by the dogs were recorded systematically.
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3. Results
In the present study, 40 clinical cases of suspected canine
ehrlichiosis exhibiting at least 2 of the classical symptoms
were included for diagnostic, clinical, hematological,
and biochemical characterization of canine monocytic
ehrlichiosis in the Mumbai region
3.1. Blood and buffy coat smear examination
In the current investigation, peripheral blood and buffy
coat smears of 40 cases suspected for canine ehrlichiosis
were prepared in duplicate and stained with the
Giemsa and Field methods. Only 1 dog (2.5%) showed
intracytoplasmic organisms in the mononuclear cells. The
organisms were stained purple and measured 0.5 to 1.5 µm
(Figure).
3.2. Immunological analysis
Serum of 21 samples (52.5%) revealed positive results as
demonstrated by development of a darker intensity of the
color of the test spot as compared to the reference spot on
the comb. Eleven dogs showed a high positive reaction, 9
revealed medium titer, and 1 dog exhibited a low positive
reaction. The dog that revealed organisms in the blood
smears had a high positive ELISA titer. The 20 dogs that
did not reveal organisms in the blood/buffy coat smears
showed positive indication of the disease by ELISA. Thus
the agreement between the 2 methods in the diagnosis of
canine ehrlichiosis was found to be 4.76%.

Figure. Intracytoplasmic rickettsiae in lymphocyte.

At present, the diagnosis of canine ehrlichiosis is
based on dot-ELISA, since it is the only tool available for
widespread application. Hence, the results obtained in the
current investigation were also analyzed to note breed, age,
and sex predisposition. However, in the present study no
such trend was noted (Table 1). Analysis of results of dotELISA with respect to age of the dogs (Table 2) revealed
a higher occurrence in adult dogs of 1 to 8 years old,

Table 1. Breed-wise predisposition to canine ehrlichiosis.
Breed

No. of dogs examined

No. of positive dogs

Small breeds
Lhasa Apso

1

1 (100%)

Pug

3

1 (33.33%)

Pekingese

1

1 (100%)

Maltese

1

0 (00.0%)

Spitz

6

5 (83.33%)

Cocker Spaniel

5

2 (40.0%)

French Bull dog

1

0 (00.0%)

Total

18

10 (55.55%)

Large breeds
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Labrador

6

4 (66.66%)

Mastiff

2

2 (100%)

German Shepherd

8

2 (25.0%)

Golden Retriever

2

Total

18

1 (50.0%)
9 (50%)

Nondescript

4

Grand total

40

2 (50%)
21 (52.5%)
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Table 2. Age-wise predisposition to canine ehrlichiosis.
Age

No. of dogs examined

No. of positive dogs

Young (below 1 year)

11

4 (36.36%)

Adult (1 to 8 years)

23

14 (60.86%)

Old (above 8 years)

6

3 (50%)

Total

40

21 (52.5%)

followed by senile dogs, and it was distinctly low in young
dogs below 1 year old. Moreover, the disease was found
to be more common in male as compared to female dogs
(Table 3), with no specific breed predisposition (Table 1).
3.3. Molecular diagnosis of canine ehrlichiosis by PCR
Only 3 samples (7.5%) showed positive reaction on
amplification with genus specific primers. Owing to the poor
sensitivity of standard PCR, conventional and single step

nested PCR was attempted on the genus specific amplicons
using the species specific primers. The band of species
specific amplification obtained at 387 bp was subjected
to DNA sequencing and was homologous to GenBank
accession number JN121380.1. The nPCR gave better results
as compared to conventional PCR (Table 3). In the present
work, 8 (20%) of the 40 samples revealed a positive reaction.
The dog that revealed presence of the organisms in the

Table 3. Results of diagnostic methods employed for canine ehrlichiosis (n = 40).
Case no.

Blood/buffy coat smear examination

ELISA titer

nPCR diagnosis

1

–

1:320–1:1280

√

2

–

1:80–1:160

√

3

–

1:160–1:320

√

4

–

1:80–1:160

√

5

–

1:320–1:1280

√

6

–

1:80–1:160

–

7

–

1:320–1:1280

–

8

–

1:320–1:1280

–

9

–

1:80–1:160

–

10

–

1:320–1:1280

–

11

–

1:320–1:1280

–

12

–

1:320–1:1280

–

13

–

1:160–1:320

–

14

–

1:80–1:160

–

15

–

1:20–1:40

–

16

–

1:320–1:1280

√

17

–

1:320–1:1280

–

18

√

1:320–1:1280

√

19

–

1:160–1:320

–

20

–

1:80–1:160

√

21

–

1:320–1:1280

–

Total

01 (2.5%)

21 (52.5%)

8 (20.0%)
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blood samples was also positive by nested PCR. Similarly all
8 dogs that showed positive PCR results were also positive
for anti-Ehrlichia antibodies as revealed by dot-ELISA.
The quantitative analysis of dot-ELISA titers of dogs with
nPCR positive results revealed that 4 of the 8 samples had
high antibody titers, 3 had medium positive titers, and 1 dog
had a low antibody titer. Thus, there was 38.09% agreement
between nPCR and ELISA results and 12.5% agreement
between nPCR and blood/buffy coat smear examination.
3.4. Clinical characterization of canine ehrlichiosis
The 8 cases that revealed positive results with dot-ELISA
and nPCR were selected for clinical characterization of
canine monocytic ehrlichiosis. The parameters included
for the purpose were categorized in 2 groups: clinical signs
and physical examination.
Depression and anorexia were the primary concerns of
most of the pet owners at the time of presentation of the
case to the veterinarians. Bleeding tendencies in the form
of epistaxis, hematuria, and melena were also encountered
in 50% of the dogs. Physical examination revealed fever
in 100% cases, splenomegaly in 62.5% cases, paleness of
visible mucus membranes indicating anemia in 52.5%
cases, and petechial/ecchymotic hemorrhages on oral
mucosa, penis, and conjunctiva in 50% cases of confirmed
canine ehrlichiosis. Ticks were encountered on the body in
50% of the dogs.

3.5 Hematological and biochemical profiles in canine
monocytic ehrlichiosis
3.5.1 Hematological profile
The most prominent feature noted in the study was
thrombocytopenia as all the dogs (100%) revealed values
below the normal range. The values of total erythrocyte
count, hemoglobin percentage, and packed cell volume
of 4 (50%) out of the 8 dogs specified in Table 4 were on
the lower side of the reference scale, indicating an anemic
trend, which corresponds precisely with the clinical
findings noted in this study. Three dogs (case no. 2–4)
had total erythrocyte counts below the normal range;
4 dogs (case no. 1–4) showed subnormal hemoglobin
percentages, and 1 dog had a low packed cell volume. The
analysis of anemia based on erythrocytic indices such as
mean corpuscular hemoglobin and mean corpuscular
hemoglobin concentration revealed that 1 dog (case no.
4) had a normochromic normocytic (nonregenerative)
trend and the remaining 3 dogs (case no. 1–3) showed
hypochromic anemia; 1 dog (case no. 1) also revealed a
microcytic trend. The remaining 4 dogs (case no. 5–8) did
not reveal anemia. Leukocytosis was evident in 5 (62.5%)
out of the 8 dogs. Differential leukocytic counts of these
5 cases exhibited relative lymphocytosis in 2 cases, and
relative neutrophilia in 1 case (Table 5).

Table 4. Hematological profile (erythrocytic) of canine ehrlichiosis.
Case
no.

Temp.
(F)

TEC
(106/μL)

Hb
(g/dL)

PCV
(%)

MCV
(fL)

MCHC
(g/dL)

1

219.2

6.30

9.5

43.18

50.9

22.00

Hypochromic
microcytic
anemia

2

224.6

4.17

9.0

28.4

68.1

21.60

Hypochromic
normocytic
anemia

3

217.4

3.14

7.1

24.5

72.0

28.90

Hypochromic
normocytic
anemia

4

217.4

4.52

10.2

32.2

71.23

31.68

Normochromic
normocytic
anemia

5

224.9

8.30

16.4

51.5

64.0

31.9

–

6

224.6

5.37

12.4

38.7

72.6

32.4

–

Remarks

7

219.9

7.71

17.9

51.2

66.40

34.96

–

8

217.4

7.9

15.4

38.7

54.9

32.1

–

Range (Avg.)

217.4 – 224.9

3.14–8.30
(5.92)

7.1–17.9
(12.23)

24.5–51.5
(38.54)

50.9–72.0
(65.01)

21.6–34.96
(29.44)

-

Reference values

101–102

5.5–8.5

12–18

37–55

60–77

31–34
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Table 5. Hematological profile (thrombocytic and leukocytic) of canine ehrlichiosis (n = 8).
Differential leukocyte count (%)

Case no.

TLC
(×103/μL)

L

N

M

E

B

Thrombocyte
(×105/μL)

1

6.9

45

49

01

05

0

0.11

Thrombocytopenia

2

27.4

26

73

01

0

0

0.38

Thrombocytopenia,
leukocytosis

3

38.3

07

82

10

01

0

0.11

Thrombocytopenia,
leukocytosis, neutrophilia

4

18.7

23

69

01

07

0

1.54

Thrombocytopenia,
leukocytosis

5

9.07

18

64

10

08

0

0.68

Thrombocytopenia

6

22.2

32

62

03

03

0

0.80

Thrombocytopenia,
leukocytosis

7

12.6

13

85

01

01

0

0.02

Thrombocytopenia

8

20.5

32

62

01

05

0

0.28

Thrombocytopenia,
leukocytosis

6.9–38.3
(19.46)

7-45
(24.5)

49–85
(68.25)

1–10
(3.5)

0–8
(3.75)

0

0.02–1.54
(0.49)

-

6–18

12–30

60–77

3–10

2–10

2–5

-

Range
(Avg.)
Reference
values (Avg.)

3.5.2. Biochemical profile
The same lot of blood and sera samples from confirmed
Ehrlichia cases was subjected to estimation of enzymes and
other components that denote liver and kidney functions.
Bilirubin, SGPT, and SGOT levels of all the dogs were well
within the normal range barring 1 or 2 exceptions with
marginal increase. Alkaline phosphatase was found to
be elevated in 4 cases. Although hepatomegaly has been
reported to be associated with this infection, it is not a
constant finding that characterizes the disease. Owing to
normal levels of serum bilirubin, it can be concluded that
the anemia noted in the present study was not a primary
result of destruction of erythrocytes. As regards protein
estimation, it was evident that 5 out of the 8 dogs exhibited
normal values. Kidney profiles, represented by levels of
blood urea nitrogen (BUN) and serum creatinine, of the
8 dogs included in the study did not reveal any conclusive
trend though 1 dog showed slight increase in BUN.
4. Discussion
Canine ehrlichiosis, a common entity in dogs in India
including Mumbai, is prima facie diagnosed on the basis
of clinical signs of fever, splenomegaly, hemorrhages on
visible mucosa, and bleeding tendency. However, these

Remarks

clinical signs are also seen in other infectious diseases like
leptospirosis and other conditions; therefore differential
diagnosis is essential for proper curative and prophylactic
treatment. At present, in most of the laboratories in
India, the emphasis is given to either demonstration of
the organisms in blood or buffy coat smears or use of
commercially available dot-ELISA kit for detection of
anti-Ehrlichia antibodies. However, both these techniques
have their own limitations that pose a serious problem for
clinicians to recognize the exact status of the infection and
prognosis. In the present study, the morphometric features
of the organisms matched the description of E. canis (12–
14). However, the level of parasitemia was extremely low.
Similar observations of low detection rate and low levels
of parasitemia were also recorded by Woody and Hoskins
(15), Juyal et al. (16), Thriunavukkarasu et al. (17), Waner
et al. (5), and Nakaghi et al. (18), in spite of the exhibition
of typical signs of the disease. Previous authors reported
as low as 0.2% parasitemia in dogs infected with E. canis,
which means 1 out of 500 circulating leukocytes was
infected with the organisms. On the other hand, Katyal
(19), Lakshmanan (10), Mallapur (20), and Samaradhni
et al. (21) reported a higher detection rate as revealed by
17.58%, 55%, 18.9%, and 5.86% prevalence, respectively.
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This discrepancy in the detection of rickettsia might be due
to the clinical phase of the infection, tenacity of laboratory
personnel to inspect large numbers of cells in each smear,
and occurrence of other diseases with similar symptomatic
expression. Thus, demonstration of organisms in blood
samples, though confirmative, is not a reliable method of
diagnosis (9,15,18).
It was also noted that the prevalence (19) as well as
severity of clinical signs (19,22) was higher in German
Shepherds. Thriunavukkarasu et al. (23) and Lakshmanan
(10) noted a higher prevalence in pure breed dogs as
compared to nondescript local breeds. This discrepancy
in the breed predisposition might be due to a number
of factors such as nutritional status, immunological
competence, and susceptibility of different breeds to
tick infestation (24). In our study, we did not note any
such trend. However, we found the incidence of canine
ehrlichiosis to be higher in males as compared to females,
whereas Lakshmanan (10) reported a reverse trend.
Similarly, dot-ELISA based on antibody detection
does not diagnose early infection and differentiate current
and past infections. The trend of disparity between the 2
diagnostic tools, the conventional and immunodiagnostic
methods, is obviously due to low levels of parasitemia
leading to detection of less number of cases. In contrast,
ELISA, being one of the most sensitive assays that detects
even very low levels of antibody titers, showed a positive
reaction in a higher number of cases. Nevertheless, higher
detection rates elicited by dot-ELISA in the present study
could also be attributed to 2 vital factors; false positive
results due to cross reactivity (25) and failure of the assay
to differentiate current and past infection (26,27). One
more drawback reported to be associated with dot-ELISA
or any other immunodiagnostic methods is failure of the
tool to detect early infection. McBride et al. (28) remarked
that IgM and IgG antibodies are not detectable until at
least 1 to 3 weeks postinfection.
The 16S rRNA gene fragment that was amplified in
this study was also exploited by Iqbal et al. (6), McBride
et al. (28), Inokuma et al. (29), and Unver et al. (30) with
reasonably reliable results. The negative nPCR sample (n =
15) may also be explained by the capacity of the organisms
to “hide” in splenic macrophages (4). Although all the
cases included in the present study were clinical, there was
every possibility that some of these may represent past
infection as it takes a considerably long time to alleviate
some of the symptoms such as splenomegaly and anemia.
Nevertheless, some of these symptoms may be due to other
etiological origins (leptospirosis, hemoprotozoa, etc.) as
revealed by the fact that 19 (47.5%) out of the 40 cases
included in the study showed negative results by all the
3 diagnostic procedures. This scenario also indicates that
clinical diagnosis has its own limitations and thus warrants
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the use of PCR for recognition of the active phase of the
infection (5,6). Previous authors opined that, owing to
convenience and direct indication of active infection, PCR
is more suitable for reliable diagnosis. In contrast, dotELISA, though user friendly and quick, may not detect
early infection due to inadequate immunostimulation,
leading to false negative results, and may not rule out
past infection due to persistence of antibodies in the
circulation, leading to false positive results. In the present
work, none of the 19 dogs with dot-ELISA negative results
showed nPCR positive results and thus superiority of
PCR over serodiagnostic approach though anticipated
was not proved. Overall comparison of the results of the 3
diagnostic methods evaluated in this work clearly indicates
that PCR-based diagnosis has the ability to overcome the
problem of underdetection of cases by blood smear/buffy
coat examination as well as the problem of overdetection
of the cases by dot-ELISA. In addition, the technique also
has very good prognostic value and can be employed for
reliable judgment of chemotherapeutic efficacy. In the
future, sensitivity, specificity, and simplicity of PCR can
be further improved by implementing modifications like
real-time PCR and more significantly multiplex PCR for
combined differential diagnosis of blood and rickettsial
infections in dogs.
4.2. Hematological and biochemical profile
All the dogs included in the study showed
thrombocytopenia. However, thrombocytopenia, though
an important hematological finding, does not rule out
other diseases like leptospirosis and other conditions.
Three reasons have been put forth in the literature to
explain development of thrombocytopenia. Smith et al.
(31) suggested that thrombocytopenia in E. canis infection
is mainly due to large-scale destruction of the cells in
the spleen that begins a few days after the infection, but
Waner (32) pointed out that bone marrow hypoplasia
leading to impairment of normal functions is the primary
cause of pancytopenia including thrombocytopenia.
The development of thrombocytopenia has also been
attributed to an immunopathological mechanism by
Waner et al. (5), who demonstrated significant levels of
serum antiplatelet IgG, 17 days after experimental E. canis
infection that resulted in the removal of antibody adsorbed
thrombocytes by the mononuclear phagocyte system in
the liver and spleen. The authors hypothesized that E. canis
infection in dogs altered the immune system, resulting
in overproduction of natural antiplatelet antibodies of
increased affinity. Thus, owing to a severe drop in the
cell count, it appears that the presence of antiplatelet
antibodies is one of the major causes of thrombocytopenia;
involvement of nonimmunological mechanisms may also
contribute in aggravating the condition.
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The nonregenerative anemia, noted in a solitary case in
the present study and also recorded by Thriunavukkarasu
et al. (23) and Waner et al. (26), might be due to bone
marrow hypoplasia leading to impaired production
of cellular components of blood. The variation in the
type of anemia can be attributed to several influential
factors such as nutritional status, iron reserves in the
body, concurrent infection, and age of the infected dogs.
Total leukocytic counts of the 8 cases ranged from 6900
to 38,300/µL (average 19,458/µL). Three cases showed
hyperglobulinemia with a reverse albumin:globulin ratio
probably due to increased levels of gamma globulins in
long-standing cases (5).
5. Conclusion
nPCR detected a greater number of cases than blood smear
examination and a lower number of cases than dot-ELISA,
which appeared to be logical owing to the extremely low
level of parasitemia in blood smears and persistence of
circulating antibodies of past infection. In addition, the
ability of the technique to identify the active phase of

infection is useful for reliable prognosis of the disease
and judgment of chemotherapeutic efficacy. However,
the constraints of time consumption, tedious steps, and
availability of thermal cycler limit its routine use.
Clinical analysis of the cases revealed that, though
prolonged depression, anorexia, and frequent episodes
of pyrexia were the presenting signs, the disease exhibits
its presence with a recurrent bleeding tendency and
hemorrhages on the visible mucosa. However, laboratory
investigation is mandatory for differential diagnosis.
Hematological analysis of Ehrlichia confirmed cases
revealed thrombocytopenia in all the dogs. The other
findings noted inconsistently in the study were anemia of
different types and leukocytosis with relative deviation of
the differential leukocyte counts.
Biochemical profiles of the dogs with confirmed
ehrlichiosis showed hyperglobulinemia with a reverse
albumin-globulin ratio in 3 cases. All other parameters
indicating liver and kidney functions did not reveal a
conclusive trend.
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